- Mexico's Supreme Court has
voted to decriminalize adult use cannabis, allowing adults to apply
for permits to cultivate and consume their own cannabis
- Khiron reiterates plans to enter Mexican medical cannabis
market in 2021 through previously announced clinic and education
strategy
- Recent regulatory and supply chain advances accelerate the
Company's entry into the medical market by several months
TORONTO, June 30, 2021 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN) (OTCQX:
KHRNF)(Frankfurt: A2JMZC), a
vertically integrated medical cannabis leader with core operations
in Latin America and Europe, today reiterates its plans to enter
the Mexican medical cannabis market in 2021, following a landmark
vote by the Mexican Supreme Court to decriminalize adult use
cannabis. The decision of the Supreme Court underscores the
political and social commitment to normalize the use of cannabis in
Mexico.
Vicente Fox, Khiron Director and
former President of Mexico,
comments, "I believe Mexico will
be the largest legal cannabis market in the world, and with a
proven strategy for Latin America
and the knowledge and track record to execute, Khiron remains at
the forefront of this exciting market. Today's vote by the Supreme
Court is an important step forward on the road to full legalization
in Mexico."
With extensive experience developing magistral preparations,
generating clinical evidence, operating pharmacies, and exporting
highly regulated cannabis products, Khiron's experience in
Colombia is expected to provide
competitive advantages for its entry into Mexico's medical cannabis market.
About Khiron Life Sciences Corp.
Khiron is a leading
vertically integrated medical cannabis company with core operations
in Latin America and Europe. Leveraging wholly-owned medical health
centres and proprietary telemedicine platforms, Khiron combines a
patient-oriented approach, physician education programs, scientific
expertise, product innovation, and agricultural infrastructure to
drive prescriptions and brand loyalty with patients worldwide. The
Company has a sales presence in Colombia, Peru, Germany
and the UK, and is positioned to commence sales in Mexico and Brazil in 2021. The Company is led by
Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and
diverse executive team and Board of Directors.
Visit Khiron online at investors.khiron.ca and on Instagram
@khironlife.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vicente-fox-khiron-board-member-and-former-president-of-mexico-applauds-mexican-supreme-courts-advancement-of-cannabis-laws-301323194.html
SOURCE Khiron Life Sciences Corp.